Malignant Breast Neoplasm — Trials

Malignant Breast Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,628
Recruiting: 1,398
Ph III recruiting: 152
Growth YoY: +22.4%
Industry share: 18%
Top sponsor: Fudan University
Termination share: 25.6%
Trials / 1,000 deaths: 61.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,368)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04487912	Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer	withdrawn	Phase 4	0	University Hospital, GhentOTHER	1	May 14, 2021	clinicaltrials
NCT02822196	Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral Mastectomies	withdrawn	Phase 4	0	The University of Texas Health Science Center, HoustonOTHER	1	Sep 16, 2020	clinicaltrials